Changes in Pain Sensitization During a Clinical Trial of OnabotulinumtoxinA for Endometriosis-Associated Chronic Pelvic Pain

BI Karp, Noemi Salmeri, Shah Jp, Ninet Sinaii, HK Tandon, Vy Phan, JV Aredo, Pamela Stratton
In: Toxicon · 2024 · vol. 237 , pp. 107418 · doi:10.1016/j.toxicon.2024.107418 · W4391067698
article OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This clinical trial investigated the effects of onabotulinumtoxinA on pain sensitization in patients experiencing chronic pelvic pain related to endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK